In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a "master regulator" ...
Piper Sandler analyst David Amsellem raised the firm’s price target on Corcept Therapeutics (CORT) to $131 from $128 and keeps an Overweight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback